Table 1 Baseline characteristics of IBD patients
From: Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia
Characteristic | CD (N = 258) | UC (N = 249) | Total (N = 507) |
|---|---|---|---|
Age, years | 33.99 ± 13.18 | 37.97 ± 15.25 | 35.96 ± 7.09 |
Gender | |||
 Male, n (%) | 133 (54.51) | 111 (45.49) | 244 (48.13) |
 Female, n (%) | 125 (47.53) | 138 (52.47) | 263 (51.87) |
Comorbidity, n (%) | |||
 0 | 225 (87.21) | 195 (78.31) | 420 (82.84) |
 1–2 | 29 (11.24) | 46 (18.47) | 75 (14.79) |
 ≥ 3 | 4 (1.55) | 8 (3.21) | 12 (2.37) |
Medication, n (%) | |||
 1–3 | 107 (41.47) | 81 (32.53) | 188 (37.08) |
 4–6 | 101 (39.15) | 103 (41.37) | 204 (40.24) |
 ≥ 7 | 50 (19.38) | 65 (26.10) | 115 (22.68) |